Skip to main navigation Skip to search Skip to main content

Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques

  • Robert M. Brenner
  • , Ov D. Slayden
  • , Anita Nath
  • , Y. Y. Tsong
  • , Regine Sitruk-Ware

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Ulipristal (UPA; CDB-2914) is a progesterone receptor modulator with contraceptive potential. To test its effects when delivered by an intrauterine system (IUS), we prepared control and UPA-filled IUS and evaluated their effects in rhesus macaques. Study Design: Short lengths of Silastic tubing either empty (n=3) or containing UPA (n=5) were inserted into the uteri of 8 ovariectomized macaques. Animals were cycled by sequential treatment with estradiol and progesterone. After 3.5 cycles, the uterus was removed. Results: During treatment, animals with an empty IUS menstruated for a mean total of 11.66±0.88 days, while UPA-IUS treated animals bled for only 1±0.45 days. Indices of endometrial proliferation were significantly reduced by UPA-IUS treatment. The UPA exposed endometria were atrophied with some glandular cysts while the blank controls displayed a proliferative morphology without cysts. Androgen receptors were more intensely stained in the glands of the UPA-IUS treated endometria than in the blank-IUS treated controls. Conclusions: In rhesus macaques, a UPA-IUS induced endometrial atrophy and amenorrhea. The work provides proof of principle that an IUS can deliver effective intrauterine concentrations of Ulipristal.

Original languageEnglish (US)
Pages (from-to)336-342
Number of pages7
JournalContraception
Volume81
Issue number4
DOIs
StatePublished - Apr 2010

Funding

We thank Kunie Mah for her expert work in immunocytochemistry, Andrea Lawson for help with computerized morphometrics, and the morphology core of the Eunice Kennedy Shriver NICHD/NIH Cooperative Agreement U54 (HD 18185) for histology support. This work was further supported by NIH grants RR00163 and HD 43209 as well as the Population Council .

FundersFunder number
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of HealthHD 43209, RR00163
Population Council
Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of HealthP30HD018185

    Keywords

    • CDB-2914
    • Endometrium
    • Intrauterine
    • Rhesus macaque
    • Ulipristal

    ASJC Scopus subject areas

    • Reproductive Medicine
    • Obstetrics and Gynecology

    Fingerprint

    Dive into the research topics of 'Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques'. Together they form a unique fingerprint.

    Cite this